Literature DB >> 2962782

Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.

B S Edwards1, R S Zimmerman, T R Schwab, D M Heublein, J C Burnett.   

Abstract

The current studies were designed to investigate the mechanisms in the intact anesthetized dog that control the release of atrial natriuretic factor (ANF). In vitro, mechanical stretch of atrial tissue produces an increased release of ANF. In vivo, changes in atrial pressure correlate positively with circulating ANF levels. The present investigations used 6 open-chest anesthetized dogs to evaluate the role of atrial pressure versus atrial stretch, the latter determined by atrial transmural pressure, in the release of ANF. In a paired design, animals underwent cardiac tamponade followed by constriction of the aorta and pulmonary artery. Tamponade produces a balanced increase in intra-atrial and pericardial pressures. Thus, despite an elevated atrial pressure, there is no increase in transmural pressure producing atrial stretch. Great artery constriction increases intra-atrial but not pericardial pressure, resulting in an increase in atrial transmural pressure and atrial stretch. Cardiac tamponade increased right atrial pressure (0.8 +/- 0.3 to G.6 +/- 0.6 mm Hg, p less than 0.001) and pulmonary capillary wedge pressure (3.7 +/- 0.6 to 8.8 +/- 0.6 mm Hg, P less than 0.001). Constriction of the aorta and pulmonary artery also increased right atrial pressure (1.5 +/- 0.8 to 6.3 +/- 0.8 mm Hg, p less than 0.05) and pulmonary capillary wedge pressure (4.6 +/- 0.3 to 7.8 +/- 1.0 mm Hg, p less than 0.05). Atrial transmural pressure increased only during great artery constriction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2962782     DOI: 10.1161/01.res.62.2.191

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  72 in total

1.  Hyponatraemia secondary to an inappropriately high release of antidiuretic hormone in cardiac tamponade.

Authors:  P H Groves; A M Shah; S J Hutchison
Journal:  Br Heart J       Date:  1990-09

2.  Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion.

Authors:  D B Northridge; J McMurray; S Ray; A Jardine; H J Dargie
Journal:  BMJ       Date:  1989-09-02

3.  An immunocytochemical study of the sinuatrial node and atrioventricular conducting system of the rat for atrial natriuretic peptide distribution.

Authors:  J N Skeper
Journal:  Histochem J       Date:  1989-02

Review 4.  Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

Authors:  Cameron S Brand; Janet K Lighthouse; Michael A Trembley
Journal:  J Mol Cell Cardiol       Date:  2019-04-28       Impact factor: 5.000

5.  Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery.

Authors:  F Valsson; S E Ricksten; T Hedner; S Lundin
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

6.  Relationship between status of plasma atrial natriuretic peptide and heart rate variability in human subjects.

Authors:  Yuji Kasamaki; Yoichi Izumi; Yukio Ozawa; Masakatsu Ohta; Ayako Tano; Ichiro Watanabe; Atsushi Hirayama; Tomohiro Nakayama; Hiroshi Kawamura; Dilxat Himit; Maisumu Mahemuti; Akira Sezai
Journal:  Heart Vessels       Date:  2012-02-28       Impact factor: 2.037

Review 7.  Future pharmacologic agents for treatment of heart failure in children.

Authors:  Brady S Moffett; Anthony C Chang
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655

8.  Effect of ryanodine on atrial natriuretic peptide secretion by contracting and quiescent rat atrium.

Authors:  M Laine; M Weckström; O Vuolteenaho; O Arjamaa
Journal:  Pflugers Arch       Date:  1994-02       Impact factor: 3.657

Review 9.  Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome.

Authors:  G Martel; P Hamet; Johanne Tremblay
Journal:  Mol Cell Biochem       Date:  2009-11-25       Impact factor: 3.396

10.  Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction.

Authors:  Rochus Witthaut; Christian Busch; Peter Fraunberger; Autar Walli; Dietrich Seidel; Günter Pilz; Ralph Stuttmann; Norbert Speichermann; Ljifane Verner; Karl Werdan
Journal:  Intensive Care Med       Date:  2003-08-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.